Milestones

Fuzeon

• Completed NDA submission

• Completed European application

• FDA response on “priority review”

• Potential FDA approval & launch

• Potential European approval

T-1249

• Initiation of Phase II Trials

Sept. 16

Sept. 19

Oct. 10

1Q03 / 2Q03

1H03

2003

Previous slide

Next slide

Back to first slide

View graphic version